Buscar
Mostrando ítems 1-10 de 578
Platelet activation in experimental arterial thrombosis.
(1987-12-01)
Platelet aggregates were studied in dogs with induced arterial thrombosis, by the method of Wu and Hoak. Blood was withdrawn from a jugular vein and from the femoral vein on the operated side 24 h after thrombus induction ...
Effect of different glycosaminoglycans in a guinea-pig carotid-artery thrombosis model
(Elsevier B.V., 1994-09-15)
Heparin is the most frequently used drug for the prevention and treatment of thrombosis. Its use, however, is restricted by its side-effects. To study the efficacy of other glycosaminoglycans that could substitute heparin ...
Effect of different glycosaminoglycans in a guinea-pig carotid-artery thrombosis model
(Elsevier B.V., 1994-09-15)
Heparin is the most frequently used drug for the prevention and treatment of thrombosis. Its use, however, is restricted by its side-effects. To study the efficacy of other glycosaminoglycans that could substitute heparin ...
Platelet activation in experimental arterial thrombosis.
(1987-12-01)
Platelet aggregates were studied in dogs with induced arterial thrombosis, by the method of Wu and Hoak. Blood was withdrawn from a jugular vein and from the femoral vein on the operated side 24 h after thrombus induction ...
The Kallikrein Inhibitor from Bauhinia bauhinioides (BbKI) shows antithrombotic properties in venous and arterial thrombosis models
(Elsevier B.V., 2014-05-01)
The Bauhinia bauhinioides Kallikrein Inhibitor (BbKI) is a Kunitz-type serine peptidase inhibitor of plant origin that has been shown to impair the viability of some tumor cells and to feature a potent inhibitory activity ...
EFFECT of DIFFERENT GLYCOSAMINOGLYCANS in A GUINEA-PIG CAROTID-ARTERY THROMBOSIS MODEL
(Elsevier B.V., 1994-09-15)
Heparin is the most frequently used drug for the prevention and treatment of thrombosis. Its use, however, is restricted by its side-effects. To study the efficacy of other glycosaminoglycans that could substitute heparin ...
Effect of different glycosaminoglycans in a guinea-pig carotid-artery thrombosis model
(Elsevier B.V., 2014)